WallStreetZenWallStreetZen

NASDAQ: SRTA
Strata Critical Medical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SRTA

Based on 3 analysts offering 12 month price targets for Strata Critical Medical Inc

Min Forecast
$8.00+98.02%
Avg Forecast
$8.00+98.02%
Max Forecast
$8.00+98.02%

Should I buy or sell SRTA stock?

Based on 3 analysts offering ratings for Strata Critical Medical Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SRTA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SRTA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SRTA stock forecasts and price targets.

SRTA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-25
lockedlocked$00.00+00.00%2026-03-25
lockedlocked$00.00+00.00%2025-12-02

1 of 1

Forecast return on equity

Is SRTA forecast to generate an efficient return?

Company
-0.32%
Industry
-27.15%
Market
144.93%
SRTA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SRTA forecast to generate an efficient return on assets?

Company
-0.27%
Industry
-25.33%
SRTA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SRTA earnings per share forecast

What is SRTA's earnings per share in the next 2 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.10-120.4%
Avg 2 year Forecast
-$0.01-102.04%

SRTA revenue forecast

What is SRTA's revenue in the next 2 years based on estimates from 6 analysts?

Avg 1 year Forecast
$274.6M+39.27%
Avg 2 year Forecast
$299.5M+51.93%
SRTA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SRTA revenue growth forecast

How is SRTA forecast to perform vs Airports & Air Services companies and vs the US market?

Company
39.27%
Industry
49.77%
Market
187.5%
SRTA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SRTA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SRTA vs Airport Stocks

TickerPricePrice TargetUp/downsideConsensus
SRTA$4.04$8.00+98.02%Strong Buy
UP$0.49N/AN/A
ASLE$6.60$6.00-9.09%Hold
SOAR$0.29N/AN/A
CAAP$27.07$27.75+2.51%Buy
View Top Airport Stocks

Strata Critical Medical Stock Forecast FAQ

Is Strata Critical Medical Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: SRTA) stock is to Strong Buy SRTA stock.

Out of 3 analysts, 2 (66.67%) are recommending SRTA as a Strong Buy, 1 (33.33%) are recommending SRTA as a Buy, 0 (0%) are recommending SRTA as a Hold, 0 (0%) are recommending SRTA as a Sell, and 0 (0%) are recommending SRTA as a Strong Sell.

If you're new to stock investing, here's how to buy Strata Critical Medical stock.

What is SRTA's earnings growth forecast for 2026-2027?

(NASDAQ: SRTA) Strata Critical Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Airports & Air Services industry's average forecast earnings growth rate of 21.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,535.23%.

Strata Critical Medical's earnings in 2026 is $41,347,000.On average, 6 Wall Street analysts forecast SRTA's earnings for 2026 to be -$8,872,893, with the lowest SRTA earnings forecast at -$11,934,910, and the highest SRTA earnings forecast at -$6,393,702.

In 2027, SRTA is forecast to generate -$887,289 in earnings, with the lowest earnings forecast at -$852,494 and the highest earnings forecast at -$913,386.

What is SRTA's revenue growth forecast for 2026-2027?

(NASDAQ: SRTA) Strata Critical Medical's forecast annual revenue growth rate of 39.27% is not forecast to beat the US Airports & Air Services industry's average forecast revenue growth rate of 49.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 187.5%.

Strata Critical Medical's revenue in 2026 is $197,141,000.On average, 6 Wall Street analysts forecast SRTA's revenue for 2026 to be $23,883,739,102, with the lowest SRTA revenue forecast at $22,855,527,432, and the highest SRTA revenue forecast at $24,707,526,286.

In 2027, SRTA is forecast to generate $26,054,988,111 in revenue, with the lowest revenue forecast at $25,020,687,201 and the highest revenue forecast at $26,835,280,724.

What is SRTA's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: SRTA) forecast ROA is -0.27%, which is higher than the forecast US Airports & Air Services industry average of -25.33%.

What is SRTA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year SRTA price target, the average SRTA price target is $8.00, with the highest SRTA stock price forecast at $8.00 and the lowest SRTA stock price forecast at $8.00.

On average, Wall Street analysts predict that Strata Critical Medical's share price could reach $8.00 by Mar 25, 2027. The average Strata Critical Medical stock price prediction forecasts a potential upside of 98.02% from the current SRTA share price of $4.04.

What is SRTA's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: SRTA) Strata Critical Medical's current Earnings Per Share (EPS) is $0.50. On average, analysts forecast that SRTA's EPS will be -$0.10 for 2026, with the lowest EPS forecast at -$0.14, and the highest EPS forecast at -$0.07. In 2027, SRTA's EPS is forecast to hit -$0.01 (min: -$0.01, max: -$0.01).

What is SRTA's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: SRTA) forecast ROE is -0.32%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.